Literature DB >> 8200963

Paroxysmal nocturnal hemoglobinuria and the glycosylphosphatidylinositol anchor.

E T Yeh1, W F Rosse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200963      PMCID: PMC294434          DOI: 10.1172/JCI117234

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  74 in total

1.  TAP transcription and phosphatidylinositol linkage mutants are defective in activation through the T cell receptor.

Authors:  E T Yeh; H Reiser; A Bamezai; K L Rock
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

Review 2.  The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors.

Authors:  P T Englund
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

3.  Studies on phosphatidylinositol phosphodiesterase (phospholipase C type) of Bacillus cereus. I. purification, properties and phosphatase-releasing activity.

Authors:  H Ikezawa; M Yamanegi; R Taguchi; T Miyashita; T Ohyabu
Journal:  Biochim Biophys Acta       Date:  1976-11-19

4.  Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria.

Authors:  T Wiedmer; S E Hall; T L Ortel; W H Kane; W F Rosse; P J Sims
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

5.  A deficiency in CDw52 (CAMPATH-1 antigen) of paroxysmal nocturnal hemoglobinuria lymphocytes.

Authors:  S Nagakura; T Kawaguchi; K Horikawa; M Hidaka; N Iwamoto; K Takatsuki; H Nakakuma; T Kagimoto
Journal:  Blood       Date:  1993-12-15       Impact factor: 22.113

6.  Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells.

Authors:  T Kamitani; A K Menon; Y Hallaq; C D Warren; E T Yeh
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

Review 7.  Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins.

Authors:  M G Low
Journal:  FASEB J       Date:  1989-03       Impact factor: 5.191

8.  Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.

Authors:  M A Davitz; M G Low; V Nussenzweig
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

9.  Phosphatidylethanolamine is the donor of the terminal phosphoethanolamine group in trypanosome glycosylphosphatidylinositols.

Authors:  A K Menon; M Eppinger; S Mayor; R T Schwarz
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

10.  Early lipid intermediates in glycosyl-phosphatidylinositol anchor assembly are synthesized in the ER and located in the cytoplasmic leaflet of the ER membrane bilayer.

Authors:  J Vidugiriene; A K Menon
Journal:  J Cell Biol       Date:  1993-06       Impact factor: 10.539

View more
  5 in total

1.  Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.

Authors:  Jason P Cooper; Rafic J Farah; Philip A Stevenson; Ted A Gooley; Rainer Storb; Bart L Scott
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-01       Impact factor: 5.742

2.  Urokinase receptor is a multifunctional protein: influence of receptor occupancy on macrophage gene expression.

Authors:  N K Rao; G P Shi; H A Chapman
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  An uncleaved glycosylphosphatidylinositol signal mediates Ca(2+)-sensitive protein degradation.

Authors:  P C Pauly; C Klein
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

4.  Diagnostic significance of measurement of the receptor for urokinase-type plasminogen activator on granulocytes and in plasma from patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Weiqiang Gao; Zhaoyue Wang; Xia Bai; Yuyun Li; Changgeng Ruan
Journal:  Int J Hematol       Date:  2002-05       Impact factor: 2.490

5.  Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14.

Authors:  R F Noel; T T Sato; C Mendez; M C Johnson; T H Pohlman
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.